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DECREASING COST ASSOCIATED MEDICATION NONADHERENCE 
 
 
An Abstract of the Scholarly Project by 
Shawn E. Raymond 
 
 
Medication cost is a major contributor for patient medication nonadherence. Take 
in the fact that a large population lives in poverty, many cannot afford to pay the retail 
prices associated with purchasing their medications. By incorporating wholesale 
medications into a charitable health clinic, the reduced cost of medications for treatment 
of both acute and chronic illnesses could be passed on to those in need thereby decreasing 
cost associated medication nonadherence. Nurse Practitioners in the state of Kansas are 
not afforded the privilege to purchase, repackage and distribute or resell wholesale 
medications like their physician counterparts. If current legislation were changed to allow 
this to happen, even if it is only in the setting of the charitable healthcare clinics, those 
individuals who are uninsured and in poverty would have more affordable access to 
prescription medications. By increasing the affordability of the medications and 
decreasing cost associated medication nonadherence, the health status of this population 
could be greatly improved.  
 Keywords: wholesale medications, retail medications, medication nonadherence, 
medication adherence, medication compliance, medication noncompliance, advanced 
practice nurse, nurse practitioner, charity, charitable health, rural health, cost associated 
noncompliance, cost associated nonadherence, medication cost, poverty. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
Description of the Clinical Problem 
 
 Medication costs have always been a barrier to patient medication adherence in 
the treatment of acute and chronic illnesses throughout the United States and around the 
World. “Prescription medication costs increase financial burden, often leading 
individuals to engage in intentional nonadherence” (Martin, Shreffler, Schoster, & 
Callahan, 2012, p. 236). Medication nonadherence leads to worsening of both acute and 
chronic illnesses, and at the same time increases the overall cost of treating those 
illnesses by requiring additional diagnostics, treatments and even hospitalizations. It has 
been estimated that approximately 125,000 deaths in the United States each year can be 
attributed to medication nonadherence (Bosworth et al., 2012, p. 2). The total cost 
estimates for nonadherence range from $100-$300 billion each year, and include both 
direct and indirect costs (Bosworth et al., 2012, p. 2). When taken into account that 1.2 
billion people around the world live in extreme poverty, this problem is greatly 
compounded (Theis, 2013). To show how prevalent the topic is within scholarly 
literature, Goldberg, DeKoven, Schabert, and Coyle (2009) performed a review of the 
literature that spanned 40 years, 1967-2007, to show the magnitude in which medication 
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nonadherence was written about. Results of that review are illustrated in Figure 1 (see 
Appendix A). In 1977, approximately 300 articles were written on medication adherence 
that year alone; 30 years later in 2007, there were approximately 4,500 articles written 
within that same one-year timespan. 
Significance 
 Many individuals often attempt to extend their medication prescriptions by 
purposefully skipping doses, and in worst case scenarios do not get them filled because 
they cannot afford them. By showing a definite link between cost of medications and 
medication adherence by patients, this project will demonstrate that allowing medications 
to be sold at wholesale cost will increase medication adherence. Medication 
nonadherence, related to cost, can effectively be decreased by utilizing wholesale 
medication throughout the United States. Also, by reducing the costs of those 
medications necessary to treat both acute and chronic illnesses, patients will keep more of 
the money they earn, effectively helping to increase their financial stability and quality of 
life. 
Purpose 
 The purpose of this project is to propose a legislative change that will allow Nurse 
Practitioners (NPs) to incorporate wholesale medications into a NP operated Charitable 
Health Clinic (CHC) in rural southeast Kansas. By doing this, data can be collected to see 
if offering medications at wholesale cost will increase medication adherence, based on 
the reduced cost associated with the purchasing the medications needed for treating the 
individual’s acute or chronic illness. According to Iuga and McGuire (2014), “Reducing 
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out-of-pocket costs leads to better medication adherence across many diagnoses. There is 
a linear relationship between the magnitude of patient cost sharing and the level of 
adherence.” At times, statements are voiced from individuals that directly correlate to the 
cost associated with the treatment option/s chosen by the provider; statements like “I 
can’t afford that.” or “we’ll have to wait until payday.” The CHC that will be referenced 
in this project is run by donations only; there is no cost associated with being seen by the 
provider. By eliminating the cost associated with being seen by a provider, the hope is 
that the individuals will be able to afford the medications, at the wholesale price, thus 
increasing medication adherence for acute and chronic illnesses by those individuals 
using the CHC.  
 In the state of Kansas, NPs are required to have a Collaborative Practice 
Agreement with a Physician to practice. Physicians within the state of Kansas that offer 
wholesale medications in their clinics are able to buy these medications in bulk, 
repackage the medications, and resell the medications to their patients; NPs cannot. It is 
yet to be determined what process it will take to incorporate wholesale medications into 
the CHC at the time of this writingt. This project will be utilized to petition the Kansas 
state legislators, to seek change within the state giving NPs equal privileges as physicians 
to purchase, repackage and dispense or resell wholesale medications. 
To start, a comparison was made to determine what the cost difference was 
between wholesale and retail medications. An online medication wholesaler, 
Andameds.com, was used to collect wholesale prices of a few common medications in 
the treatment of both acute and chronic illness. These wholesale prices were then 
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compared to the retail prices for the same medications using GoodRX.com. By 
comparing the prices of these medications, it was apparent the cost savings that could be 
passed on to the patients was fairly significant. Table 1 (see Appendix A) lists the 
medications with breakdown of cost per pill, as well as cost for a standard course of 
treatment, whether it is a 5-day, 10-day or 30-day course. Prices were taken from each 
website and compiled into Table 1 on September 15, 2015.  
Theoretical Framework/Conceptual Analysis  
 The theoretical framework used for this specific work is based on the Health 
Belief Model (HBM). The HBM was originally written in the 1950s by a group of 
psychologists at the United States Public Health Services (Janz & Becker, 1984). The 
HBM was utilized as “a conceptual formulation for understanding why individuals did or 
did not engage in a wide variety of health related actions, and provided considerable 
support for the model” (Janz & Becker, 1984, p. 1). Initially, the HBM was written in an 
attempt to understand why people did not undergo preventative care for the early 
detection of “asymptomatic disease” (Janz & Becker, 1984, p. 2). The HBM later went on 
to incorporate aspects of how people responded to symptoms of the disease process, as 
well as medication adherence. 
 The HBM first addressed Perceived Susceptibility which constitutes an 
individual’s perception of the risk to contract a disease or illness. Second, the HBM 
addressed Perceived Severity of the illness if contracted, as well as the physical, 
emotional, and economic costs of leaving the condition untreated. Next, Perceived 
Benefits were addressed. This established if there were any benefits to leaving the 
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condition untreated or obtaining treatment. Finally, Perceived Barriers, defined as 
anything that hindered the individual from obtaining treatment for the condition, were 
addressed. 
 Due to the fact that the CHC sees those patients who are uninsured or 
underinsured, the total cost associated with the treatment of the acute and chronic 
illnesses plays a large part in nonadherence. Many patients are denied services when they 
do not have the monetary means or insurance coverage to pay for the testing or 
medications up front. By addressing the HBM factors that hinder individuals from getting 
the diagnostics and treatments they need, this project hopes to show an increase in the 
health and wellness of this population. 
Project Objective 
 The objective of this project was to petition area senators and legislators to 
change the current legislation in the state restricting Advanced Practice Nurses (APNs) to 
purchase, repackage and dispense or resell wholesale medications to the 
uninsured/underinsured individuals that are cared for at NP run CHCs within the State of 
Kansas. 
Definition of Key Terms 
adherence  
“The WHO defines adherence as ‘the extent to which the persons' behavior 
(including medication-taking) corresponds with agreed recommendations from a 
healthcare provider’” (Lam & Fresco, 2015, p. 1). 
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charitable  
 1. “Generous in giving money or other help to the needy.” 
 2. “Mild or tolerant in judging others; lenient.” 
 3. “Of, for, or concerned with charity: a charitable organization” 
 (“Charitable,” 2009). 
clinic  
“A facility, often associated with a hospital or medical school that is devoted to 
the diagnosis and care of outpatients” (“Clinic,” 2003). 
compliance  
“The extent to which the patients' behavior (including medication-taking) 
coincides with medical or healthcare advice” (Lam and Fresco, 2015, p. 1). 
healthcare  
“The prevention, treatment, and management of illness and the preservation of 
mental and physical well-being through the services offered by the medical and 
allied health professions” (“Healthcare,” 2003). 
medication adherence  
“The extent to which patients take medication as prescribed by their health care 
providers”; “the patient’s conformance with the provider’s recommendation with 
respect to timing, dosage, and frequency of medication taking during the 
prescribed length of time” (Viswanathan et al., 2012, p. 1).  
nurse practitioner 
“[Registered] nurses who are prepared, through advanced education and clinical 
training, to provide a wide range of preventive and acute health care services to 
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individuals of all ages” (O'Grady, 2008, p. 605). Nurse Practitioners “take health 
histories and provide complete physical examinations; diagnose and treat many 
common acute and chronic problems; interpret laboratory results and x-rays; 
prescribe and manage medications and other therapies; provide health teaching and 
supportive counseling, with an emphasis on prevention of illness and health 
maintenance; and refer patients to other health professionals as needed” (O'Grady, 
2008, p. 605). 
Abbreviations 
Advance Practice Nurse/s    APN/APNs  
 Charitable Health Clinic    CHC 
 Chronic Care Model     CCM 
 Centers for Medicare and Medicaid Services  CMS 
 Doctor of Nursing Practice    DNP 
 Health Belief Model     HBM 
Kansas State Board of Pharmacy   KSBP 
 Kansas State Board of Nursing   KSBN 
 Medicare Part D     MPD 
 Medication Therapy Management   MTM 
 Nurse Practitioner/s     NP/NPs 
 Out of Pocket      OOP 
 Socioeconomic Status     SES 
 Southeast Kansas     SEK 
 Verdigris Valley Charitable Health Clinic  VVCHC 
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World Health Organization    WHO 
Logic Model  
 The Verdigris Valley Charitable Health Clinic (VVCHC) Logic Model was 
specifically created for this project. This logic model breaks down factors that were and 
will need to be addressed prior to initiating, and throughout this evolving project. The 
logic model is broken down into three separate sections: inputs, outputs and outcomes-
impacts. The input section compiles a list of primary issues that face this project overall. 
Without all of these aspects falling into place, this project will not succeed. The outputs 
section details what each input’s activities and participation level will be within this 
project. The outcomes-impact section lays out short-, medium- and long-term goals that 
will need to be achieved for completing and continuing of this project. An example of the 
logic model would be the following:  
 Inputs:  Pittsburg State University’s Irene Ransom School of Nursing 
 Outputs: Activities: Approval and oversight of the DNP Scholarly Project 
Participation: Guidance and oversight of the project, peer review 
project to ensure compliance with evidence based research. 
Outcomes: Short: Project was approved by the DNP advisor and committee. 
   Medium: Project was validated through peer review. 
   Long: Scholarly Project was defended successfully. 
The complete VVCHC Logic Model can be found in Table 2 (see Appendix A). 
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Chapter Summary 
 Cost is a significant factor in medication nonadherence and it leads to worsening 
of both acute and chronic illnesses. With medication adherence comes a substantial 
increase in the costs associated with the treatment of worsening illness, both direct and 
indirect. Cost estimates range from $100-300 billion each year (Bosworth et al., 2012). A 
review of the literature by Goldberg, DeKoven, Schabert, and Coyle (2009) shows the 
vast increase in articles written on the subject matter over the years with approximately 
4,500 articles published in 2007 alone (Figure 1, see Appendix A).  
The purpose of this project was to not only incorporate wholesale medications 
into a NP operated CHC in rural southeast Kansas, and to legislate for policy changes 
through the state government to give NPs the same privileges that physicians have when 
it comes to buying, repackaging and dispensing or reselling wholesale medications. By 
offering medications at wholesale cost this project will determine if there is an increase 
medication adherence, based on the reduced costs associated with purchasing the 
medications needed to treat an individual’s acute or chronic illness.  
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CHAPTER II 
 
 
REVIEW OF THE LITERATURE 
 
 
Introduction 
 The review of literature will help support the pretense of this project, that cost is a 
factor to medication adherence. This chapter focuses on the various populations that are 
affected from the cost of purchasing retail medications, as well as the laws that keep 
APNs from purchasing, repackaging and dispensing/reselling wholesale medications. The 
information highlighted in this section was used to educate the legislative representatives 
on not only the problem that cost association has on medication adherence, but a solution 
to the problem at hand.  
To validate that the costs associated with medication is a factor in adherence, a 
meta-analysis of the published literature was conducted. The literature was reviewed for 
validity of subject matter, currency of information, and publication type. Only the work 
that was published in scholarly, peer reviewed sources within the last five years was 
included. The information was gathered in a range of various settings, but all information 
did reveal that, among other variables, cost was a determining factor in medication 
adherence in the treatment of acute and chronic illnesses. 
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 Literature was gathered from multiple resources using various search criteria. 
Various online databases were utilized within this review of literature to include 
CINAHL Plus with Full Text, PubMed, PubMed Central, PubMed Clinical Queries and 
Proquest Nursing & Allied Health Source; another online resources utilized was Google 
Scholar. Search sting queries consisted of multiple combinations of the following; 
medication adherence, medication compliance, cost, costs, afford, affordability, reduced 
adherence, reduced compliance, wholesale, wholesale medications, charity, charitable, 
charitable health, charitable health clinic, retail pharmacy, wholesale pharmacy, 
socioeconomic status, poverty, poor, working poor, uninsured, underinsured, fixed 
income. Initially very few articles met the criteria for this study, but after extensive 
research the following literature was chosen to conduct this review. 
Medication Adherence 
 Medication adherence is key to increasing the health status of those who 
experience acute and chronic illnesses. According to Mackey et al., (2015), the World 
Health Organization reported medication adherence for those with chronic illnesses only 
averaged 50% in developed countries (p.2). An estimated 50-60% of those with chronic 
conditions are noncompliant with medication treatment regimens (Bosworth et al., 2011, 
p. 2). Medication nonadherence overall drastically reduces the optimal health and 
wellness of an individual, and also increases the overall costs of individual treatment, 
possibly requiring more office visits or hospitalizations due to their poor health state. 
Approximately 1.6 billion prescriptions filled within the Unites States each year are not 
taken as prescribed (Bosworth et al., 2011, p. 2). 
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Socioeconomic factors that play into nonadherence include socioeconomic status 
(SES), whether patients are insured, underinsured, or uninsured, availability to medical 
care; and availability to pharmaceuticals. Mackey et al (2015, p. 2), found that “patient 
characteristics such as age, sex, race, and education are associated with medication 
adherence,” as well as “financial burdens such as low income or socioeconomic status, 
lack of prescription drug coverage, and high out-of-pocket costs”. In addition, WHO 
divides the circumstances that lead to nonadherence “into five categories: socioeconomic 
factors, therapy-related factors, patients-related factors, condition-related factors, and 
health system/ health care team (HCT) related factors” (Lam & Fresco, 2015, p. 2).  
Therapy-related factors include various medication reactions such as rash, nausea, 
vomiting and anaphylaxis. Other therapy-related factors include inability to purchase 
medications, unavailability of medications or even in rural areas inability to get to where 
the therapy-related items are sold. Patient-related factors include refusing to take 
medication or not having the medication available at the time it is to be administered. 
Condition-related factors include inability to take the medication as prescribed due to 
disease process or medical condition, inability to take medication due to cognitive 
function, inability to take the medication due to decreased recall of current treatment 
plan, and inability to take medications due to pain, blindness, weakness, loss of function 
of upper extremities, nausea or vomiting. Health care team (HCT) related factors consist 
of issues such as medical professionals forgetting to inform the patient of changes to the 
medication plan, forgetting to call new medication in, or forgetting to tell the patient that 
they had called something in. Other examples could include the provider not taking into 
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account the individual’s SES or insurance information when calling or faxing in a new 
medication that the individual cannot afford and ineffective communications between the 
HCT and the individual. 
For over 40 years, researchers have used various methods to determine adherence, 
but none have ever been considered the gold standard (Lam & Fresco, 2015, p. 2). 
Therefore, multiple techniques must be utilized in studies to enhance the effectiveness of 
the gathered data. Without testing multiple techniques to measure adherence, researchers 
could possibly misrepresent the data and show more or less adherence than there actually 
is. This error in data representation could cause harmful and unnecessary consequences at 
all levels of the healthcare delivery system. 
Uninsured/underinsured. Out of the hundreds of sources reviewed, the article 
that most specifically related to this project was Alton, March, Mallary, and Fiandt’s 
(2015) “Medication Adherence in a Nurse Practitioner Managed Clinic for Indigent 
Patients.” As the authors themselves state, “Little is published in the literature about 
medication adherence rates among patients who are medically indigent and patients 
receiving primary care from nurse practitioners (NPs)” (Alton et al., 2015, p. 433). This 
study was a cross-sectional analysis that looked at adherence and barriers to treatment 
plans in the indigent population that were specifically cared for in a NP run health clinic 
and were deemed to be uninsured or low income. Participants were surveyed on 
adherence issues and barriers to treatment with “surveys eliciting demographic 
information, self-report of medication adherence, health literacy, and barriers to 
adherence” (Alton et al., 2015, p. 433). An unusually large return rate 77% was noted in 
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this study. Two definitive causes of this return were most frequently identified, and one 
of those was inability to afford medications (62.5%). The other involved Hispanic 
patients’ inability to understand medication labels. The takeaway point of this project was 
the need to improve patient access to affordable medications, which could in effect 
increase rates of medication adherence within that particular clinic and patient 
population. 
 A qualitative study published in the journal Health & Social Work in 2011 
explored various aspects of adherence and nonadherence in low-income individuals with 
multiple comorbid disease processes. The study accounted for both the physical and 
mental aspects of chronic illness (Mishra, Giola, Childress, Barnet, & Webster, 2011). 
They found that various factors played into the adherence level, or lack thereof, of 
medication treatment plans. Some of those factors that affected medication treatment 
plans included “medication side effects, fear of harm from medication, fear of 
dependence on medication, complex instructions, suboptimal communications with 
doctor, suspicion about doctors’ and pharmaceutical companies’ motives in prescribing 
medication, and the high cost of medications” (Mishra et al., 2011, p. 249). Also 
identified were various motivators for medication adherence that actually increased 
medication adherence in that study; these were “faith, support from family members and 
doctors, and focused health education and self-management support” (Mishra et al., 2011, 
p. 249). During the study Mishra et al. also noted financial status as being a large 
contributor to nonadherence as well; the medications were too expensive and just 
increased patients’ financial strain. One participant in this study stated, “I was working 
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and I got laid off and I had to pay for my medications and it cost me $97 to get all of my 
prescriptions and I don’t have $97, so I had to choose what medication was the most 
important” (Mishra et al., 2011, p. 252). This, many times, is what individuals on fixed 
incomes or low incomes face when they have chronic illnesses. Individuals with acute 
and chronic illnesses can have every intention of being adherent with their primary 
provider’s medication treatment plans but if they cannot afford the medications there is 
no way they can be adherent. 
Chronically ill/elderly. Medication nonadherence, due to cost can be 
increasingly influenced by the number of medications an individual is on. This state of 
taking multiple medications is called polypharmacy. Older adults have vastly unique and 
challenging barriers, that may not be shared by other age groups. According to Marcum 
and Gellad (2012), barriers for older adults could include “managing multi-drug 
regimens, cognitive impairment, functional limitations, financial restraints, use of 
multiple health care providers, [and/] or transportation limitations” (p. 1). The more 
chronic illnesses an individual has, the more medications it will take to control the 
progression of those chronic conditions.  
There are multiple stages in which an elderly or chronically ill individual could be 
nonadherent; these include getting the prescription filled when new medications are 
prescribed, starting to take the medications as prescribed, continuing to take the 
medication as prescribed (in those who suffer from chronic conditions), and taking the 
medication for its intended purpose (Marcum & Gellad, 2012). Multiple studies have 
been conducted with regard to nonadherence in the elderly; these studies have shown that 
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approximately 50% of the elderly population are nonadherent on at least one of their 
medications, whether intentionally or unintentionally (Marcum & Gellad, 2012). Marcum 
and Gellad (2012) identified three different types of medication nonadherence, 
nonfulfillment, nonpersistence, and nonconforming (p. 1). Primary nonadherence 
revolves around not picking up the medication that was prescribed to the individual, 
nonpersistence is stopping a medication prior to taking the full course of the prescribed 
medication, and nonconforming relates to not taking the medication as prescribed, 
whether it is taking doses at the wrong time or skipping doses altogether (Marcum & 
Gellad, 2012). There are various reasons individuals may be noncompliant, but per 
Marcum and Gellad (2012). “The most common health-system barrier to medication 
adherence is cost. Cost is clearly more of a problem for those patients taking more 
medications, and thus polypharmacy may affect adherence through higher cost-sharing” 
(p. 4). 
 Mackey et al. (2012) performed a study using the Chronic Care Model (CCM) to 
see if this model of treatment would increase medication adherence compared to those 
who were not treated under this model. They sent out surveys to 40 small community 
healthcare clinics. Participants in this study were 18 years or older and had at least one 
chronic illness (mean 2.4). The surveys were based on the Morisky Medication 
Adherence Scale, the Patient Assessment of Chronic Illness Care, and a set of frequently 
used items developed by Piette and colleagues (Piette, Heisler, & Wagner, 2004) that 
helps assess cost-related burdens. A total of 2,634 surveys were given out with 2,392 
returned for an astonishing, 90.8% completion rate. Statistical analysis was performed on 
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the collected data and showed “prescription costs and perceptions of care experiences 
were significantly associated with medication adherence” and a “high prevalence of poor 
adherence among chronically ill individuals” (Mackey et al., 2012, p. 5). With regard to 
the CCM, patients that were treated under this model did show improvement with 
medication adherence, compared to those who were not treated under it. 
Medicare supplemental population. Members of the Medicare supplemental 
population face unique challenges regarding nonadherence. Mixon, Neal, Bell, Powers, 
and Kripalani (2015) stated that “Older adults typically take more medications than 
younger adults due to multimorbidity associated with advanced age” (p. 1). Musich et al. 
(2015) found that those individuals who were on a Medicare supplemental insurance plan 
took approximately seven different prescription medications each year, “resulting in 
substantial out-of-pocket drug copayments, in addition to Medicare Supplement and 
Medicare Part D (MPD) premiums” (p. 1208). Seniors on Medicare who may have 
supplemental coverages also fall into the area of being able to not afford certain 
prescriptions based on cost or many have multiple medications so the cost increases for 
the amount of medications they may be on. Because many older Americans are on a fixed 
income and are at or below the poverty line medication costs can tax an already limited 
budget, based from many older adults being on a fixed income. Per Musich et al. (2015) 
out of pocket spending (OOP) rates were very sensitive to the rate of medication 
nonadherence, “OOP spending increases with higher numbers of medications, medication 
nonadherence increases” (p. 1209). As for Mixon et al. (2015), “before the 
implementation of MPD (prescription drug insurance) in the USA, 2 million older adults 
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were nonadherent to their drug regimen due to lack of prescription coverage” (p. 5). Even 
though MPD came about to give these millions of older adults’ medication coverage, 
there is still what is known as the donut hole in which the person reverts back to paying 
full price for medications. The donut hole starts when a person reaches the annual 
spending limit set by Medicare. Based on the amount of chronic illness and the amount 
and cost of medications the individual is on, the individual may hit that donut hole 
midway through the fiscal year while others may hit towards the end of the year. Mixon 
et al. (2015) showed in their article that the ‘donut hole’ increased medication 
nonadherence in the Medicare population “with fewer prescriptions filled and more gaps 
in therapy” (p. 5). The donut hole is currently in the process of phasing out, but this will 
not take place for another four years (2020). Until that time though, many poor, older 
adults will continue to hit the donut hole and have to make the decision whether to 
purchase their medications or purchase food and pay their utilities. 
 In 2013 a study was done by Carr-Lopez et al. during the MPD open enrollment 
period. Medication Therapy Management (MTM) teams were dispatched to six different 
central and northern California cities. Student pharmacists under direct supervision 
provided the services to the individuals enrolling in MPD. A series of questions were 
asked by the student pharmacists and answers were recorded. Out of 1,547 individuals 
showing up for the open enrollment clinic, only 586 of the individuals were provided 
with MTM. Per Carr-Lopez (2014), inclusion criteria for MTM was established by the 
Centers for Medicare and Medicaid (CMS) and allowed the MPD organizers to require 
the participants of this study to take up to eight different medications in order to meet 
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standardized drug requirement for the provision of MTM services. Data analysis from the 
2012 study revealed that “75% of MPD plan sponsors required a beneficiary to be taking 
seven or eight medications to qualify for MTM” (Carr-Lopez et al., 2014, p. 1282). Out 
of those 586 that were offered MTM, only 532 (91%) agreed to participate in the study. 
Data was then taken and processed using various statistical analysis. Only 30% of those 
who participated in the study admitted to medication nonadherence, but an interestingly 
higher number (48%) asked questions about missed dosing. Forgetfulness was the most 
reported factor in nonadherence, but “Cost of medication, even with the MPD 
prescription drug benefit, was a barrier to adherence” (Carr-Lopez et al., 2014, p. 1281).  
Laws Governing the Distribution of Medications 
 Between the federal government, state government and the Kansas State Board of 
Pharmacy, the laws that govern how prescription medications are handled within the state 
are determined. The Pure Food and Drug Act of 1906 is one of the earliest laws that 
focused on the purity of drugs utilized in interstate commerce (Dusen & Spies, 2006). 
This act did not address any false advertising or claims to those drugs; it focused on 
curtailing interstate commerce of those drugs that were mislabeled or contaminated. In 
1937, after a compounding error in Tennessee that killed over 100 people, there was a 
public outcry for the federal government to intervene. In 1938, the Pure Food and Drug 
Act was replaced by the Food, Drug and Cosmetic Act (Dusen & Spies, 2006). For the 
first time in history the law mandated that all new drugs be approved prior to entering the 
market. The companies looking for approval had to show safety and efficacy prior to 
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being approved. Pharmacist began compounding medications in their pharmacies to be 
used by the public.  
Under the Food, Drug and Cosmetic Act (1938), these compounded medications 
were considered new drugs and they had to be tested and approved by the FDA prior to 
dispensing. Because these medicines that were being compounded were in fact a 
combination of individual medications that had already been approved by the FDA, a 
new law was enacted. In 1997, the Food and Drug Administration Modernization Act 
replaced the Food, Drug and Cosmetic Act of 1938 (Dusen & Spies, 2006). The new act 
would effectively eliminate the FDA’s ability to say that compounded drugs were 
classified as new drugs. 
In 1951, the Durham-Humphrey Amendment was established (Dusen & Spies, 
2006). This act would cease dispensing medications without a prescription. Up until that 
time individuals could walk in off the street, tell the clerk what they wanted and get it. In 
1970, The Comprehensive Drug Abuse Prevention and Control Act was enacted (Dusen 
& Spies, 2006). This act would effectively categorize controlled substances into 5 
different classes: Schedule I, II, III, IV and V. Also, this act would dictate the storage, 
dispensing and record keeping of controlled substances.  
Also in 1970, the Poison Prevention Packaging Act was enacted (Dusen & Spies, 
2006). This act would mandate child-resistant packaging for all medications. Up to that 
point, poisonings from medications was “considered by pediatricians to be the leading 
cause of injuries among children under 5 years of age” (Dusen & Spies, 2006, p. 27). In 
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1987 came along the Prescription Drug Marketing Act. This act would combat the 
problem of diverting bulk medicines onto the “gray market” (Dusen & Spies, 2006). This 
 act would later be rolled into the Food, Drug and Cosmetic Act (Dusen & Spies, 2006).  
 The Omnibus Budget Reconciliation Act of 1990 established that pharmacists had 
to give each individual that picked up a prescription mandatory education on the 
medication being purchased. The reason this act was initiated was to positively affect 
therapeutic outcomes, thus saving the federal government money in the process (Dusen & 
Spies, 2006). 1996 saw the dawning of the Health Insurance Portability and 
Accountability Act. This act placed limits on individuals protected health information. 
Current Laws Affecting APNs in the State of Kansas 
 Most state in the U.S. allow physicians to dispense medications to some extent 
(Optum, 2015, para. 1). In many aspects relating to why the author pursued this project, 
“Physicians perceive drug dispensing as reducing the drug cost to [their] patients, 
reducing the cost of healthcare [and] improving drug adherence” (Munger, 2014, p. 40). 
As per Kansas law, medications dispensed by physicians can only be reimbursed at a rate 
equivalent to that of pharmacies, and also the insurance company may require prior 
authorization before they will pay for the medication (Optum, 2015, para. 5). 
Unfortunately, Kansas APNs do not get the same opportunities as physicians with regard 
to being able to purchase, repackage and dispense or resell wholesale medications 
without the supervision of a pharmacist. Figures 2 through 6, in Appendix A, show the 
differentiation of state practices in reference to dispensing medications by non-
pharmacist practitioners and physicians’. As these figures show, Kansas does not require 
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physicians to be licensed to dispense medications. The only restriction is how they charge 
for the medication. 
 Kansas Statutes Chapters 65 and 68 provide definitions utilized within the 
statutes, regarding this topic. The following is a list of the main definitions that are 
specific to this project:  
“‘Dispenser’ means a practitioner or pharmacist who dispenses prescription 
medication, or a physician assistant who has authority to dispense prescription-
only drugs in accordance with subsection (b) of K.S.A. 65-28a08, and 
amendments thereto” (Kansas Board of Pharmacy, 2014, p. 22).  
 “‘Mid-level practitioner’ means an advanced practice registered nurse issued a 
license pursuant to K.S.A. 65-1131, and amendments thereto, who has authority 
to prescribe drugs pursuant to a written protocol with a responsible physician 
under K.S.A. 65-1130, and amendments thereto, or a physician assistant licensed 
pursuant to the physician assistant 25 licensure act who has authority to prescribe 
drugs pursuant to a written protocol with a responsible supervising physician 
under K.S.A. 65-28a08, and amendments thereto” (Kansas Board of Pharmacy, 
2014, p. 24-25). 
“‘Practitioner’ means a person licensed to practice medicine and surgery, dentist, 
podiatrist, veterinarian, optometrist or scientific investigator or other person 
authorized by law to use a prescription-only drug in teaching or chemical analysis 
or to conduct research with respect to a prescription-only drug” (Kansas Board of 
Pharmacy, 2014, p.26). 
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“‘Prescriber’ means a practitioner or a mid-level practitioner” (Kansas Board of 
Pharmacy, 2014, p. 26). 
“‘Wholesale distributor’ means any person, partnership, corporation, or business 
firm licensed or registered in this state and engaging in the wholesale distribution 
of prescription-only drugs” (Kansas Board of Pharmacy, 2014, Article 68-14-1, p. 
118). 
 “‘Wholesale distribution” means distribution of prescription-only drugs to 
persons other than a consumer or patient, but this term shall not include any of the 
following: …, (3) the sale, purchase, or trade of a drug or an offer to sell, 
purchase, or trade a drug by a charitable organization described in section 
501(c)(3) of the U.S. internal revenue code of 1954 to a nonprofit affiliate of the 
organization to the extent otherwise permitted by law;” (Kansas Board of 
Pharmacy, 2014, Article 68-14-2, p. 119). 
Argument for APNs to Distribute Wholesale Medications 
 By viewing the definitions above, the prediction could be made that the only 
difference between the definitions of a mid-level practitioner and practitioner is the 
supervision aspect for the mid-level practitioners. In rural America, many times these two 
individuals do not work in the same office, town or even county. So, does the supervisory 
role take on a more “supervisor on paper” type of roll? Even though some states may 
have restrictions on which provider can prescribe scheduled (Drug Enforcement Agency, 
controlled) medications, all can write nonscheduled medication prescriptions. All 
practitioners (and mid-level practitioners) diagnose, treat and prescribe medications to 
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their patients and in most cases this is done without any supervision of the mid-level 
practitioners.  
Following the same definitions listed in the statutes, the term “Practitioner” 
included any person licensed to practice medicine and surgery. Even though APNs are 
not licensed to perform surgery, they are licensed to practice medicine. The only real 
piece of legislation standing in the way of APNs being able to purchase, repackage and 
dispense or resell wholesale medications is the current difference in the definitions of 
practitioners and mid-level practitioners. Possibly if future legislation were passed to give 
APNs full practice authority, this may help to sway the influence in favor for APNs being 
able to purchase, repackage and dispense or resell wholesale medications at their clinics 
without pharmacy oversight.   
 Another area that could be debated is a section in Article1635, of the Kansas 
Statute Chapter 65, that relates to the dispensing of medications by a duly licensed 
practitioner in a town where there are no registered pharmacies. This article states 
nothing in the Kansas Pharmacy Act will inhibit those individuals who are classified as 
‘duly licensed practitioners’ from purchasing, repackaging and dispensing or reselling 
medications to their patients. Following is an excerpt of that statute: 
65-1635. Dispensing and administering of drugs by duly licensed practitioners, 
…, (a) Nothing contained in the pharmacy act of the state of Kansas shall prohibit 
any duly licensed practitioner from purchasing and keeping drugs, from 
compounding prescriptions or from administering, supplying or dispensing to 
such practitioner's patients such drugs as may be fit, proper and necessary. 
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Except as provided in subsection (b) or (c), such drugs shall be dispensed by such 
practitioner and shall comply with the Kansas food, drug and cosmetic act and be 
subject to inspection as provided by law. (Kansas Board of Pharmacy, 2014, p. 
40) 
Subsection (b) references administering of medications only, and subsection (c) refers to 
registered nurses being able to dispense medications under the supervision of a 
practitioner prior to July 1, 1982.  
If one could argue that APNs were “practitioners” who are licensed to practice 
medicine within the state and are located in a town that does not have a registered 
pharmacy, it may be possible to convince the state to change its regulations and statutes 
to allow APNs the opportunity to care for their patients the same way that physicians do, 
with regard to offering wholesale medications to their patients within the clinic setting.  
Chapter Summary  
 The research definitively shows that the costs associated with medications is an 
undeniable factor in medication adherence. Through this meta-analysis of the published 
literature, collected from a wide range of various settings did reveal that among all 
variables cost was definitely a determining factor in medication adherence, in the 
treatment of both acute and chronic illnesses. 
 Mackey et al. (2015) showed that approximately half those in developed countries 
were nonadherent to their medication regimens (p.2). Also, of those with chronic 
illnesses, the percentage of those who were nonadherent with their medications increased 
to approximately 50-60% of the population (Bosworth et al., 2011, p. 2). Medication 
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nonadherence reduces the optimal health and wellness of individuals, increases the 
overall costs of treatment and increased both direct and indirect costs of medical 
treatment. Over half of the 3.2 billion prescriptions that are filled within the United States 
are not taken as prescribed (Bosworth et al., 2011, p. 2). Patient demographics, as well as 
SES have a great effect on medication adherence as well. Other factors that have been 
shown to affect medication adherence included financial burdens, lack of prescription 
drug coverage, and high out-of-pocket costs (Mackey et al., 2015, p. 2).  
There is a clear link between the cost of medications and nonadherence. In a study 
by Alton et al. (2015), which showed a 77% noncompliance rate (p. 433), the two most 
frequently identified reasons were inability to afford medications (62.5%) and inability to 
understand medication labels (Alton et al., 2015, p. 433). Mishra et al. (2011) also 
showed a definitive link between the high cost of medications and nonadherence (p. 249). 
Marcum and Gellad (2012) showed cost to be the most common health-system barrier to 
medication; especially in polypharmacy and those who had higher cost-sharing (p. 4). 
There is a great disconnect between the current regulations in place denying 
APNs the ability to dispense wholesale medications and what is best for the patient. 
When APNs are not allowed the chance to dispense wholesale medications to their 
patients, especially in the setting of a charitable health clinic, the ones that suffer are the 
patients. With regard to this project, not allowing wholesale medications into the 
charitable health clinic may delay the care provided to patients through pharmacotherapy, 
causing increased illness, increased cost, and possibly other poor outcomes to include 
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death. Legislation must be changed to incorporate a safety net for those uninsured and 
underinsured within the State of Kansas.  
Within the confines of this project, Kansas Statute Chapter 65, Article 1648 could 
be used in the meantime to help establish wholesale medications in the charitable 
health/indigent clinic. The only downfall to Article 1648 is that it would require the 
assistance of a pharmacist. This article gives authorization for a nurse’s or physician’s 
assistant to dispense medications in the absence of the pharmacist in charge (Kansas 
Board of Pharmacy, 2014). Following is an excerpt of that article: 
Kansas statutes Chapter 65, Article 1648 (d) (1) The state department of health 
and environment, any county, city-county or multicounty health department, 
indigent health care clinic, federally qualified health center and any private not-
for-profit family planning clinic, when registered by the board, may keep drugs 
for the purpose of distributing drugs to patients being treated by that health 
department, indigent health care clinic, federally qualified health center or family 
planning clinic. Distribution and control of prescription medications in a health 
department, indigent health care clinic, federally qualified health center or family 
planning clinic shall be under the supervision of a pharmacist in charge. A 
designated registered nurse or nurses or a licensed physician assistant approved 
by the pharmacist in charge shall be in charge of distribution and control of 
drugs in the health department, indigent health care clinic, federally qualified 
health center or family planning clinic under the supervision of the pharmacist in 
charge when a pharmacist is not on the premises. Drugs supplied to patients 
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when a pharmacist is not on the premises shall be limited to the quantity 
necessary to complete a course of treatment as ordered by the practitioner 
supervising such treatment. (2) The board shall adopt rules and regulations 
relating to specific drugs to be used, to recordkeeping and to storage of drugs by 
a health department, indigent health care clinic, federally qualified health center 
or family planning clinic as are necessary for proper control of drugs. (Kansas 
Board of Pharmacy, 2014, p. 53) 
Until the laws are changed to allow APNs the authority to dispense medications 
within the clinic setting without pharmacy or physician oversight, it will take a 
multidisciplinary team approach to ensure patient care is performed. This 
multidisciplinary approach will help ensure that there are no delays in the treatment of 
acute or chronic illnesses in the indigent population. By ensuring there is no delay in 
treatment, direct and indirect costs associated with patient medication nonadherence can 
effectively be reduced.  
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CHAPTER III 
 
 
PLAN 
 
 
Introduction 
 From the literature review, it has been established that cost is a substantial factor 
in medication adherence/nonadherence. It could be deduced that medication adherence 
would increase if the cost of medications decreased (Iuga & McGuire, 2014). However, 
there is some question as to how the cost of medications can be reduced when the prices 
are set by a free market enterprise, where profitability is the bottom line. The answer lies 
within offering medications at wholesale cost.  
As shown in Table 1 of Appendix A, readers can determine that many retail 
medications’ prices are marked up more than 1000%. These markups allow retail 
pharmacies to pay for their facilities, salaries and incidentals; all while making profit. 
Mattingly (2012) wrote a Chain Pharmacy Industry Profile which he stated that “the 
average cost for retail pharmacy operations is $11.34 for each prescription [filled]. This 
means that in order for a pharmacy to earn income beyond the cost of doing business, it 
must have an average reimbursement that is greater than the cost of the drug plus $11.34” 
(para. 10).  
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In a charitable health clinic, profits are not the driving force, so providing 
wholesale medications at cost passes the savings onto the patients. To help control the 
cost, the federal government set up a federal upper limit with regard to medications 
purchased through Medicaid. Some states have incorporated a maximum allowable cost 
(MAC) that pharmacies cannot go above; if the pharmacy pays more for the medication 
than the MAC, they have to take the loss associated with the sale of that medication 
(Mattingly, 2012, para. 9)  
The information gained from this meta-analysis will be utilized to enlighten the 
state legislators, as well as the Kansas State Board of Pharmacy and the Kansas State 
Board of Nursing, on not only the problem, but also a solution that will involve changing 
the current legislation to allow APNs to purchase, repackage and dispense or resell 
wholesale medications at cost in CHCs across the State. Currently, most of the state 
legislators are campaigning for the upcoming primary’s that will take place in August, 
2016. Some of the local legislators have voiced interest in hearing more about the 
research and proposed solution after the primaries are finished (L. Hibbard, personal 
communication, July, 2016), (L. Jenkins, personal communication, July, 2016).  
A policy analysis was performed on the various alternatives that could be 
incorporated into the CHC to see what would be the best alternative to pursue. A 
Practical Guide for Policy Analysis: The Eightfold Path to More Effective Problem 
Solving, written by Emeritus Professor Eugene Bardach was utilized to perform the 
policy analysis. The information from this project was placed within the eight steps and 
the decision to do the legislative presentation was chosen as the most viable alternative to 
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initiate this project. Chapter five highlights the eight step policy analysis that was used to 
analyze the alternatives that were available. 
The proposal to the state legislators was simple; take out the terminology referring 
to “mid-level practitioners,” incorporate APNs into the classification of practitioners, this 
would allow APNs to have the same privileges afforded to the physicians with regard to 
the purchasing, repackaging and dispensing or reselling of wholesale medications to their 
patients. During the process of this project, a simple cost analysis was performed to see 
whether or not it would be feasible to incorporate wholesale medications into the CHC in 
rural, southeast Kansas. Following is a summary of that feasibility study, which will be 
incorporated into the presentation to the state legislators. 
Market Analysis Research 
 The current and projected demand for medications across the nation is enormous. 
With acute and chronic illnesses come the medications to treat those illnesses. 
Approximately 3.2 billion prescriptions are filled each year within the Unites States, and 
approximately 50%, or 1.6 billion, of these prescriptions are not taken as prescribed 
(Bosworth et al., 2011, p. 2). Common sense affirms that if someone can get the same 
product for less than one tenth of the cost, they will.  
 The target market will be those individuals that are uninsured and fall below 
200% of the current poverty level. The services will be available to all individuals that 
utilize the CHC, but in order to avoid taking business away from nearby pharmacies, 
individuals with insurance will be asked to utilize retail pharmacies. Exceptions will be 
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made for those individuals who cannot afford the medications from a nearby pharmacy if 
a delay in treatment would result in rapid deterioration of their current condition. 
 Currently the CHC is only open on Wednesdays from 1:00 p.m. to 6:00 p.m. The 
CHC averages 25 patients per half day of operation. The current demand may seem not to 
justify the initial startup cost, but being able to ensure patients have access to affordable 
medications for the treatment of chronic illness will be justified through decreasing 
overall costs associated with medication nonadherence across the board. Initially only 
small quantities of the most commonly prescribed medications will be purchased. Then, 
as demand increases, the supply will be increased as well. By starting slow, adjustments 
can be made in a controlled environment instead of trying to do it when business picks 
up. 
 Competition in the area will not be a factor. This service is not being initiated to 
compete with the nearby pharmacies; it is being established as a safety net for those 
individuals that cannot afford retail prices at the nearby pharmacies, or those individuals 
who do not have transportation to the nearest retail pharmacies eight miles away. At the 
current capacity of the CHC, nearby pharmacies should not be impacted by the initiation 
of this program. 
 The location that was selected for this program will help this program to succeed. 
The clinic is centrally located between four larger communities; individuals travel up to 
60 miles to utilize the clinic. At this current time the CHC is housed within a local 
church, but property has been acquired to build a clinic on in the future. Also the 
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community where the clinic is located does not have local access to a pharmacy, so this 
will be an added service for the community.  
Key Organizational and Technological Issues 
 The current organizational structure of the clinic is that it falls under the 501(c)(3) 
of the cooperating church. Once the new clinic building is completed, the clinic will 
apply for its own 501(c)(3). The APN provider and receptionist hold positions on the 
church’s Board of Directors to represent the clinic.  
 The CHC is run by an all-volunteer staff. The current staff is made up of a 
receptionist, an LPN as office nurse, and a nurse practitioner as primary provider. Under 
the current state laws, the addition of a pharmacist to the staff is needed because current 
laws within the state of Kansas do not allow for a nurse practitioner to purchase, 
repackage or redistribute medications without pharmacy oversight. Recruitment for a 
pharmacist and pharmacy technician to join the all-volunteer staff will be the first step in 
initiating this program. If a volunteer pharmacist is not found, the next step will be 
contracting either a local pharmacist or a company that offers ePharmacy oversight. The 
clinic operates on donation only, so pricing on contracting pharmacy or ePharmacy 
support will have to be added to the current overhead cost of running the clinic. 
 The clinic has an electronic medical record (EMR) system that was initially set up 
for concierge medicine (subscription fee based, medical care practice model). The EMR 
has a module for inventorying wholesale medications and producing labels based on the 
medication information within the program. A label printer will have to be purchased 
which would be a one-time expense. Afterward, labels and pill bottles will need to be 
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purchased on a routine basis. Cost for the packaging and labels will be added to the price 
of the medication so that the program sustains itself.  
If ePharmacy services are implemented, the equipment for these services will 
need to be purchased as well. Currently, the CHC has the finances available to initiate the 
program, but maintaining the program may be a limiting factor. Grant funding is a way to 
help sustain this program and possibly to buy the equipment needed for the program. 
Financial Issues 
 Currently, while under the covering of the church, 10% of the donations go 
towards utilities and towards the church secretary handling the finances of the clinic. The 
clinic’s only operating expenses are approximately $900 per year to pay for the 
provider’s part-time malpractice insurance and $60 per month for telephone and fax 
service, which the provider pays. The clinic has substantial funds available in its account 
to sustain the current program at its current capacity. Once wholesale medications are 
incorporated, a financial audit will need to be performed so that the budget can be 
adjusted accordingly for the new expenses associated with this project. 
 Initially, the clinic will stock some of the most frequent medications the provider 
prescribes. These will include classes of medications such as antibiotics, 
antihypertensives, antiemetics, muscle relaxers, anti-inflammatories and cholesterol 
medications. The initial order will be small enough to ensure that medications will be 
used before they expire and therefore will not have to be destroyed.  
 Looking to the future, a stand-alone clinic must be built. The land has already 
been purchased and donated to the clinic so when the funds become available, the clinic 
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will be built in stages. One area that will be crucial for the development and continued 
support of this program is a small room that can be devoted to storing, repackaging and 
dispensing or reselling the wholesale medication storage roo Depending if grant funding 
comes in, or not, this project could take a few months to a few years to complete. 
Chapter Summary 
 Throughout this chapter different areas were addressed. First, the plan for 
presenting this project to attempt to get legislation changed were discussed. Also, items 
from the feasibility study were discussed including market analysis research, key 
organizational and technological issues, and financial issues. As far as being a feasible 
undertaking, the answer lies in the cost of the pharmacist support. If the pharmacist 
comes on as a volunteer, the program is highly feasible, but as the price for this service 
increases, the feasibility of this program decreases.  
 Reasons why retail pharmacies charge more than wholesale drug prices were 
discussed, and it was determined that the average cost to operate a retail pharmacy was 
$11.34 per prescription filled (Mattingly, 2012). Table 1 in the Appendix A shows that 
many of the most commonly prescribed prescriptions can be had for pennies on the dollar 
at wholesale prices, and when $11.34 is added on to each one, price markups near 4,000-
5,000%. Whereas profitability is necessary in the retail pharmaceutical industry, this 
program is about affordability and will be offered to the indigent population, by a 
nonprofit organization. There may be a slight markup for packaging, but it will not be the 
$11.34 per prescription charged by the retail pharmacies. 
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CHAPTER IV 
 
 
LEGISLATIVE PRESENTATION 
 
 
Introduction 
 As part of this project, a legislative presentation was scheduled. It was imperative 
that this project be placed in motion so that hopefully legislation change will come. 
Information gathered in the review of literature was used to validate the argument that 
cost was a definitive factor in medication adherence in all populations around the world. 
Building on that, current state laws were reviewed to show APN’s do not have the 
authority to repackage wholesale medications. Various alternatives were discussed at this 
presentation, but implementing legislation change was the focus. 
Legislative Selection 
 Congresswoman Lynn Jenkins was chosen to be the main guest at this 
presentation. Congresswoman Jenkins has a long history of supporting rural healthcare. 
Also, Congresswoman Jenkins is a member of the United States House of 
Representatives and represents the State of Kansas at the national level. Involving 
Congresswoman Jenkins in this presentation meant that she would gain direct knowledge 
of the problems highlighted in this project and be able to convey that knowledge to a 
national, congressional audience. Other state-level senators and representatives were also 
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invited to the presentation, but due to business or personal conflicts could not attend. A 
copy of the letter sent to Congresswoman Jenkins has been included in the Appendix A; 
Figure 7. 
Presentation Layout 
 The presentation was laid out in a format that would easily be followed. First a 
review of the literature was highlighted to show that cost was a large barrier to 
medication adherence in multiple populations. Information highlighted in this portion of 
the presentation included deaths attributed each year to medication nonadherence, direct 
and indirect costs associated with medication nonadherence, and the percent of the 
population that was nonadherent in regards to taking their medications. 
 Next, the presentation focused on the significance of the problem. Theis (2013) 
was quoted during the presentation to show that 1.2 billion people around the world were 
living in extreme poverty. With medication cost being the focus of this project, showing 
the high number of people living in poverty adds merit to the idea of incorporating 
wholesale medications into the charitable healthcare setting. 
 Various ways in which people can be nonadherent with their medications were 
discussed next. When people cannot afford their medications, they may ignore medical 
advice regarding dosages. The following are examples of how individuals may be 
nonadherent with their medication regimens: 1) if they are scheduled to take one pill 
daily they might take it every other day instead, 2) if a medication is supposed to be taken 
three times daily, they may only take it twice a day, and 3) they may only take the 
medication when they identify symptoms caused by not taking the medication, then the 
38 
 
discontinue the medication when the symptoms resolve. Any variation to the written 
instruction from the provider is classified as being nonadherent with the medication. 
After describing the problem and showing the significance of the problem, the 
focus shifted to the purpose of this project. The purpose of this project was to propose 
legislative change to allow NPs to purchase, repackage and dispense or resell wholesale 
medications. The specific legislation to be changed is focused on definitions used to 
differentiate between practitioners and mid-level practitioners. Kansas statutes chapters 
65 and 68 defined practitioner as “a person licensed to practice medicine and surgery, 
dentist, podiatrist, veterinarian, optometrist or scientific investigator or other person 
authorized by law to use a prescription-only drug in teaching or chemical analysis or to 
conduct research with respect to a prescription-only drug” (Kansas Board of Pharmacy, 
2014, p.26). The proposed legislative change would drop the definition of mid-level 
practitioner and change the wording to the definition of practitioner as follows: a person 
licensed to practice medicine and/or surgery, with or without a collaborating agreement 
as determined by state law. If this proposed change to drop the definition of mid-level 
practitioner and change the definition of practitioner, APNs would achieve authority 
under K.S.A. 65-1635 to purchase, repackage and dispense or resell wholesale 
medications. 
 To validate the cost savings of providing wholesale medications in a charitable 
health clinic setting a table was presented comparing costs of medications with regard to 
retail and wholesale pricing. Medications that were commonly prescribed in the 
charitable health clinic were depicted in this table. This table showed that retail prices 
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were more than 1000% of wholesale prices in most instances. The slide presentation for 
this legislation change review has been included in the Appendix A; Table 3. 
The Presentation 
On October 3, 2016, at 10:30 AM, a delegation from Kansas’s second  
Congressional District, to include the U.S. Representative from Kansas, Congresswoman 
Lynn Jenkins, met at VVCHC in Altoona, Kansas. Formal introductions were made of 
persons in attendance. As mentioned before Congresswoman Lynn Jenkins was in 
attendance with delegates from her office, including William Roe, District Director, and 
Stephanie Lightle, District Representative. Chief executive officers from two local 
hospitals were in attendance as well: Dennis Shelby, CEO of Wilson Medical Center in 
Neodesha, Kansas and Nancy McKenzie, CEO of Greenwood County Hospital in Eureka, 
Kansas. Dr. Jennifer Harris Ph.D., APRN represented Pittsburg State University, as the 
advisor to the author’s DNP scholarly project. Along with these distinguished guests 
were representatives from three local area newspapers and an area TV news station. 
The presentation garnered support from Congresswoman Jenkins and her 
delegates, who were in favor of elevating this proposal to legislative change further up in 
the state government. William Roe stated that he would attempt to connect the author to 
Kansas lawmakers prior to the next legislative session. Questions from the 2nd 
Congressional District representatives, as well as the CEOs from the area hospitals were 
fielded upon completion of the presentation. The presentation concluded with a tour of 
the facility. 
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Presentation Results 
 As a result of the presentation to 2nd Congressional District’s Congresswoman, 
Lynn Jenkins, the importance of the proposed legislative change has Congressional 
backing, thereby validating the proposal. If the Congresswoman had not been in a 
position that supported rural health, she may have not elevated this proposal to the next 
level within the state government. Due to her support of rural health care and comments 
made during her visit, this legislative change proposal could have a congressional voice 
at both the state and federal level. Also, when the legislative change proposal is presented 
to state lawmakers, hopefully support will be garnered. The change that will be sought is 
to have the current legislation changed in the future to allow APNs to be included in the 
definition of practitioner, thus giving APNs the lawful ability to purchase, repackage and 
dispense or resell wholesale medications within the state of Kansas.  
 After the presentation and questions, Congresswoman Jenkins approached the 
author for professional insight. Congresswoman Lynn Jenkins had just returned from 
Washington, D.C. where she proposed legislative change to the Social Security Act to be 
vetted prior to being resubmitted during the next legislative session in January, 2017. The 
proposed legislative exchange would include APNs and PAs as practitioners. She asked 
the author if he would be willing to look at her proposed legislation and make any 
additional changes as needed, prior to being resubmitted. Without foreknowledge of the 
Congresswoman’s actions, the legislation changes proposed in this project could actually 
come to fruition in the future. 
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CHAPTER V 
 
 
POLICY ANALYSIS 
 
 
Introduction 
 Eugene Bardach is an Emeritus Professor of Public Policy at the Goldman School 
of Public Policy, at the University of California Berkley. He wrote a book on how to 
conduct an effective policy analysis titled: A Practical Guide for Policy Analysis: The 
Eightfold Path to More Effective Problem Solving (Holquist, 2013). As stated in the title, 
Professor Bardach broke down policy analysis into eight different steps. Those steps were 
utilized to analyze the policies that inhibit APNs from being able to purchase, repackage, 
and dispense or resell wholesale medications. Within the policy analysis, alternatives 
were brainstormed and evaluated for not only plausibility but also for effectiveness, 
reliability and ease of implementation. After the analysis was completed it was evident 
that legislation change would incorporated into the action plan of implementing this 
project into rural CHCs throughout the state.  
 Based on current definitions of practitioners and midlevel practitioners, APNs are 
not authorized to purchase, repackage and dispense or resell wholesale medications. This 
chapter was dedicated to analyzing the current definitions and policies using Professor 
Bardach’s eight steps, these steps will be covered in the following sections of this 
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chapter. This policy analysis made a refutable argument for changing definitions in the 
current policy and that by doing so APNs will hopefully inherit the same rights as 
physicians when it comes to the purchasing, repackaging and dispensing/reselling of 
wholesale medications in rural CHCs. 
Define the Problem 
 The problems associated with this project are twofold. The primary problem is 
medication nonadherence related to the cost associated with purchasing retail 
medications. The second problem is that APNs are unable to purchase, repackage and 
dispense or resell wholesale medications to decrease the cost burden associated with the 
purchasing of medications for both acute and chronic illnesses. 
Assemble Some Evidence - Observations 
As outlined in the review of literature, medication costs are a barrier to 
medication adherence around the world. There are various reasons individuals may be 
noncompliant, but per Marcum and Gellad (2012) “The most common health-system 
barrier to medication adherence is cost” (p. 4). Mackey et al. (2015) showed that 
approximately half of those in developed countries were nonadherent to their medication 
regimens (p.2).  Bosworth et al. (2011) showed that approximately 1.6 billion 
prescriptions filled within the United States each year are not taken as prescribed (p. 2). 
Alton et al. (2015), showed 62.5% of individuals they surveyed claimed inability to 
afford medications as their reason for noncompliance (p. 433).  
 As far as APNs being able to purchase, repackage and dispense or resell 
wholesale medications, the problem lies in the purchasing and repackaging of wholesale 
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medications without pharmacy oversight. Advanced Practice Nurses are classified as 
mid-level practitioners in the state statutes, therefor they are not afforded the same 
opportunities as practitioners (“a person licensed to practice medicine and surgery, 
dentist, podiatrist, veterinarian, optometrist or scientific investigator or other person 
authorized by law to use a prescription-only drug in teaching or chemical analysis or to 
conduct research with respect to a prescription-only drug” (Kansas Board of Pharmacy, 
2014, p.26). If there were no differentiation between mid-level practitioners and 
practitioners, this would not be an issue and there would be no need for legislative change 
to incorporate wholesale medications in rural CHCs that are run by APNs. 
Construct the Alternatives – Future Implications 
 There are many different alternatives that can be initiated, but all of the 
alternatives hinge on oversight from a practitioner (physician) or a pharmacist. By 
utilizing a practitioner to initiate this project it would necessitate that the practitioner 
actually goes to the clinic in their off hours to repackage the medications themselves. As 
previously discussed, many times the collaborating practitioners do not live in the same 
locale as the CHCs, so this would take away from their personal time and some 
practitioners may be unwilling to do this.  Possibly searching out a practitioner that 
already has this project established in their personal clinic could be an alternative as well. 
If the practitioner would donate the cost of repackaging or do the repackaging themselves 
for a nominal fee, it could make the process sustainable while keeping the cost of the 
wholesale medications low enough that the individuals who utilize the services of the 
CHC would be able to afford.    
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 Another alternative would be to incorporate a pharmacist into the CHC. Unless 
one could be found to volunteer for this specific role, an added cost to the CHC would 
result. If a pharmacist could not be found in the vicinity of the CHC then there are 
telepharmacists that could be employed by the CHC, but this would also require the CHC 
to find a pharmacy technician to volunteer or hire to assist with the repackaging of the 
medications. In the case of the CHC listed in this project, it is run by donation only and 
this option with an added expense may not be sustainable. 
 And finally, purchasing medications in a unit dose packing would be another 
option to explore. With this option the decreased cost of purchasing medications in bulk 
would be somewhat eliminated, thus increasing the cost of purchasing wholesale 
medications by the CHC and patient’s alike. When cost is the primary reason for 
incorporating this project into a CHC, this may not be the ideal alternative. 
Select the Evaluation Criteria  
 Evaluation criteria for this project began with the scholarly project proposal. 
During this phase the review of the literature was utilized to enlighten the project 
committee of the problem that exists with the cost of retail medications and how it 
increases patient’s medication nonadherence. Also, the committee was shown the cost 
difference of medications as they relate to wholesale versus retail pricing. By gaining 
approval from the committee to proceed with the project, the author’s opinion of this 
project was validated.  
 The Health Belief Model (HBM) was chosen to evaluate and provide a framework 
for this study and to address the factors associated with nonadherence. The HBM was 
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written in an attempt to understand why people did not undergo preventative care for the 
early detection of “asymptomatic disease” along with patient response to medication 
adherence (Janz & Becker, 1984, p. 2). The proposed legislation change of this project 
could address the perceived barrier of medication cost by the individual thus effecting the 
overall outcome of the patient.  
 A legislative presentation was also used as a measure to evaluate the project. The 
information was presented to Congresswoman Lynn Jenkins and the staff that 
accompanied her to the presentation. Congresswoman Lynn Jenkins stated that this 
project was a great idea and she would get the author in contact with her state senator to 
further advance the proposal to change legislation regarding this project (L. Jenkins, 
personal communications, October 3, 2016). 
 Further evaluation will be performed during the course of this scholarly project 
and beyond. The project defense will be utilized to evaluate the legitimacy of this project 
in writing. Advancing the proposed legislative change of including APNs into the 
definition of practitioner through the state legislature will add another layer of evaluation 
from a legislative perspective. Finally initiating the wholesale medications into the CHC, 
regardless of which method is used in compliance with applicable law, will be the final 
evaluation method used for this project. 
Project the Outcomes – Health Policy/Practice Implications 
 During this phase of the policy analysis, each alternative will be analyzed to 
address the specifics of this project. This step could possibly help eliminate alternatives 
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that would not produce the desired effect. Even though it may not determine the most 
effective alternative, it will narrow down the alternatives available 
 The primary objective for this project is to propose legislative change, to allow 
APNs to purchase, repackage and dispense or resell also medications. As a means to an 
end, this alternative would be the gold standard to incorporating wholesale medications in 
a NP run, rural charitable health clinic. By getting the current legislation changed there 
would be no barrier to incorporating this project. 
 The next option would be to incorporate a pharmacist on staff at the charitable 
health clinic to perform the function of pharmacy oversight. This alternative could 
possibly increase costs associated with running a charitable health clinic, unless the 
pharmacist would volunteer their services to the clinic. Whether this would be a nearby 
pharmacist or telepharmacist could affect the overall cost associated with their service. 
Being that the clinic runs on donation only, this cost could inhibit the clinic from 
incorporating this project into existence. 
 The final alternative discussed would be to find a practice that already has this 
project incorporated. Again, there may be cost associated with that facility’s employee/s 
repackaging the wholesale medications unless those individuals volunteered their 
services to the clinic. Depending on the cost associated with this alternative, it could be a 
better option than hiring a pharmacist, but again if legislation is passed to allow APNs to 
purchase, repackage and dispense or resell wholesale medications there would be no 
additional cost. 
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Confront the Trade-Offs  
 When we confront the trade-offs, what we are ultimately doing is evaluating the 
cost/benefit ratio. The information that was obtained through the alternative analysis is 
reviewed and a summary statement is developed for each alternative. The summary 
statements will consist of two to three sentences that verbalize the actual cost of the 
alternative, as well as the benefit. 
With the initial alternative listed above, legislation change would ultimately cost 
time and effort. Educating members of the state legislation would be key when the 
proposed legislative change came before them for vote. This would ensure each one knew 
what was at stake. The benefit would be that APNs would have the authority to purchase, 
repackage and dispense or resell wholesale medications. 
The cost of the next alternative of recruiting a pharmacist would also cost time 
and effort, but it could also cost a substantial financial obligation; unless one could be 
found that would be willing to donate their time. The benefit of this alternative would be 
having additional staff so that one individual would not be responsible for the entire 
project. Another benefit would be not having to expand the time and energy to educate 
members of the state legislation. 
The cost involved with finding a facility where this project is incorporated would 
be minimal time and effort to find someone who already has this project up and going. 
There may be additional costs associated with having individuals from another facility 
repackage the wholesale medications, unless someone was found who was willing to 
donate their time and effort. The benefit to this alternative if someone was found who 
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would donate their time and services, would be saving additional expenses by buying in 
bulk instead of unit doses. Also, another benefit would be that the repackaged 
medications would already be labeled thus saving the additional time and resources to do 
that step. 
Tell Your Story 
 During this phase of the policy analysis it is essential to “consider the three types 
of audiences, (1) those that will spend 30 seconds reading your analysis, (2) those who 
will spend three minutes, and (3) those that will spend 30 minutes” (Holquist, 2013). 
These steps could also be incorporated into various private and corporate level verbal 
presentations, in various settings. Within the confines of this project, the Congresswoman 
who attended the presentation allowed for 45 minutes at the facility. In preparing for this 
meeting 20 minutes was set aside for the actual presentation. The rest of the time was to 
tour the facility, as well as answer any specific questions raised during the presentation. 
Decide – Cost Limitation  
 During this step of the policy analysis we decide on which alternative is most 
appropriate for the project. As it has been mentioned in previous times, cost is a definite 
limiting factor for this project. Above, the alternatives have been laid out and due to cost 
the legislation change would be the most cost-effective alternative to implementing this 
project. If this legislation change does not pass a different alternative will be sought. 
Which alternative would be initiated would depend on the costs associated to 
implementing that alternative. 
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Conclusion 
Medication costs continue to be an obstacle to patient medication adherence in the 
treatment of acute and chronic illnesses. “Prescription medication costs increase financial 
burden, often leading individuals to engage in intentional nonadherence” (Martin, 
Shreffler, Schoster, & Callahan, 2012, p. 236). It could be deduced that medication 
adherence would increase if the cost of medications decreased (Iuga & McGuire, 2014). 
The information gained from through this study can be used to educate state legislators, 
the Kansas State Board of Pharmacy, and the Kansas State Board of Nursing in an effort 
to define the problem and identify a solution that may involve changing current 
legislation in an effort to allow APNs to purchase, repackage and dispense or resell 
wholesale medications at cost in CHCs across the State. By offering medications at 
wholesale cost, providers can determine if an increase in medication adherence is present 
and supported by the reduced costs of purchasing medications. This project proposes a 
legislative change that would amend the definition of practitioner would allow NPs to 
purchase, repackage and dispense or resell wholesale medications. 
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APPENDIX A 
Figures and Tables 
 
Figure 1. Number of publications on medication adherence over time (Goldberg, 
DeKoven, Schabert,& Coyle, 2009) 
 
 
Figure 2. Physician Dispensing Across the Country (Optum, 2015, p. 1)  
Note: Light Blue – Legal Restrictions; Light Gray – Nonrestrictive; Dark Gray – 
Reimbursement Restrictions; Dark Blue Very Restrictive 
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Figure 3. Non Pharmacist Dispensing in the U.S. (Munger, 2014, p. 9) 
 
Figure 4. Practitioners Qualified to Dispense (Munger, 2014, p. 10) 
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Figure 5. Dispensing Practitioner Registration (Munger, 2014, p. 11) 
 
 
Figure 6. Compliance with Pharmacy Regulations When Non-Pharmacist Dispensing 
(Munger, 2014, p. 12) 
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Figure 7. Invitation Letter to Congresswoman Lynn Jenkins 
 
August 23, 2016 
 
Dear Congresswoman Jenkins:       
 
My name is Shawn Raymond and I am a Nurse Practitioner in rural southeast Kansas. I am 
completing a Doctor of Nursing Practice (DNP) degree at Pittsburg State University (inaugural 
class). Currently, I am working on a DNP Scholarly Project as part of the requirements for the 
degree program. The project goal is to educate elected government officials with the potential for 
legislative changes that would allow nurse practitioners to purchase wholesale medications, then 
repackage and dispense these medications to the uninsured/underinsured populations within rural 
communities across the state of Kansas. 
 
After graduating PSU in 2013 with a Master of Science in Nursing degree and becoming certified 
as a Nurse Practitioner, I petitioned and received approval from the Kansas Department of Health 
and Environment to open an Indigent Healthcare Clinic. In October 2014, the Charitable Health 
Clinic (free clinic) was opened in my hometown, Altoona, KS. Currently we have approximately 
450 people from a 60-mile radius that utilize the services. A review of the literature shows that 
cost is a major factor to medication adherence in the treatment of both acute and chronic illness 
and adds approximately $100-$300 billion dollars each year in direct and indirect costs 
(Bosworth et al., 2011, American Heart Journal). By being able to offer the 
uninsured/underinsured medications at wholesale cost, the hope is to increase medication 
adherence in these populations and be able to effectively increase the overall health and wellness 
of these individuals.  
 
The research of a wholesale supplier’s price list, as compared to retail pricing found retail 
markups up to and greater than 1000%. The state of Kansas currently allows physicians to 
purchase, repackage and dispense wholesale medications without pharmacy oversight. Since 
Advanced Practice Nurses are often the available providers in rural communities, it would be 
desirable to see legislation enacted that would allow nurse practitioners to be able to do the same 
as physicians, in rural charitable health clinics for the uninsured/underinsured populations that 
cannot afford the retail costs when purchasing medications. 
 
Currently, I am working to set up meetings with other state officials. As I graduate in December 
2016, it would be beneficial to visit with you more in depth about this issue if available anytime 
between now and the end of September. I can travel anywhere for a meeting, but would be 
honored to meet in Altoona, KS so you could view the facilities and programs that are offered to 
the community through the Charitable Health Clinic. 
 
Sincerely, 
 
 
Shawn Raymond, MSN, APRN, NP-C 
Verdigris Valley Charitable Health Clinic 
215 E. 13th St. 
Altoona, KS 66710 
620-xxx-xxxx (Office - Wednesdays 1-6pm) 
620-xxx-xxxx (Cell) 
Email: sraymond@xxxx.org  
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Table 1. Wholesale Medication Cost Analysis (Andamed.com and GoodRx.com, 2015) 
 
 
 
Table 2. Verdigris Valley Charitable Health Clinic Logic Model 
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Table 3. Legislative Presentation, October 3, 2017, VVCHC, Altoona, Kansas 
 
 
